What is the recommended dose of albumin (human albumin) to administer during paracentesis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Albumin Dosing for Paracentesis

Administer 6-8 grams of albumin per liter of ascitic fluid removed when performing large volume paracentesis (>5 liters). 1, 2, 3, 4

Standard Dosing Protocol

For paracentesis removing >5 liters:

  • Give 6-8 g of albumin per liter of ascites drained 1, 2, 3, 4
  • Use 20% or 25% albumin solution 3, 4
  • Administer after the paracentesis is completed, not during the procedure 3
  • Infuse slowly to prevent cardiac overload in patients with preexisting cardiomyopathy 1

Practical dose calculations:

  • 5 liters removed = 30-40 g albumin 2
  • 8 liters removed = 48-64 g albumin 2
  • Example: 100 mL of 20% albumin per 3 liters of ascites 3

Volume-Based Indications

Paracentesis >5 liters:

  • Albumin is mandatory to prevent paracentesis-induced circulatory dysfunction (PICD) 1, 2, 3, 4
  • Without albumin, PICD occurs in 70-80% of patients 1, 2
  • PICD manifests as renal impairment, hepatorenal syndrome, hyponatremia, and increased mortality 1, 2, 4

Paracentesis <5 liters:

  • Risk of PICD is low 1
  • European guidelines (EASL) still recommend albumin due to concerns about alternative plasma expanders 1
  • Consider albumin (8 g/L) in high-risk patients even with <5 liters: those with acute-on-chronic liver failure or high risk of post-paracentesis acute kidney injury 3, 4

Evidence for Mortality and Morbidity Benefit

The superiority of albumin is established by high-quality evidence:

  • Reduces PICD by 61% (OR 0.39,95% CI 0.27-0.55) compared to alternative treatments 1, 2
  • Reduces mortality by 36% (OR 0.64,95% CI 0.41-0.98) 1, 2
  • Reduces hyponatremia by 42% (OR 0.58,95% CI 0.39-0.87) 1, 2
  • Albumin is superior to dextran-70, gelatin, hydroxyethyl starch, and hypertonic saline 1, 2, 4

Reduced Dose Consideration

A pilot study suggests 4 g/L may be effective in select patients:

  • Limited to patients with low-severity cirrhosis (MELD 16-17) 1, 5
  • Showed similar rates of PICD (14% vs 20%, p=NS) and no difference in renal impairment or survival 5
  • One institutional study using 6.5 g/L (vs 8.3 g/L) showed no difference in adverse outcomes 6

However, the standard 6-8 g/L remains the official recommendation because:

  • The reduced-dose study was unblinded and underpowered 5
  • EASL guidelines maintain full-dose recommendations due to risk-benefit concerns 1
  • The mortality benefit was demonstrated with standard dosing 1, 2

Critical Safety Considerations

Limit ascites removal to <8 liters per session:

  • PICD risk increases significantly when >8 liters are removed 1, 2
  • Even with adequate albumin, limiting volume reduces complications 1, 2

Monitor for circulatory overload:

  • Infuse albumin slowly in patients with cardiomyopathy 1, 2
  • Watch for signs of pulmonary edema during infusion 1

Common Pitfall: Confusion with SBP Dosing

Do NOT confuse paracentesis albumin dosing with spontaneous bacterial peritonitis (SBP) treatment:

  • SBP requires weight-based dosing: 1.5 g/kg on day 1 and 1.0 g/kg on day 3 1, 2, 3, 4
  • SBP albumin is for patients with bilirubin >4 mg/dL or creatinine >1 mg/dL 4
  • Paracentesis albumin is calculated per liter removed, not by body weight 2, 3, 4

Physiologic Rationale

The mechanism explains why albumin is essential:

  • Rapid drop in intraabdominal pressure increases venous return and cardiac output transiently 2
  • This hyperkinetic state increases vascular shear stress, paradoxically decreasing effective arterial volume 2
  • Activation of renin-angiotensin-aldosterone system, sympathetic nervous system, and vasopressin follows 2
  • Without albumin, plasma renin activity increases >50% by day 6, defining PICD 1, 2
  • Albumin prevents this cascade and maintains effective circulating volume 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Administración de Albúmina en Paracentesis de Gran Volumen

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Albumin Infusion Protocol for Large Volume Paracentesis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Use of Albumin in Patients with Ascites

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2011

Research

Standardizing the Use of Albumin in Large Volume Paracentesis.

Journal of pharmacy practice, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.